See more : Redcastle Resources Limited (RC1.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Teligent, Inc. (TLGT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Teligent, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Generations Bancorp NY, Inc. (GBNY) Income Statement Analysis – Financial Results
- Spielvereinigung Unterhaching Fußball GmbH & Co. KGaA (S6P.DE) Income Statement Analysis – Financial Results
- Arizona Metals Corp. (AZMCF) Income Statement Analysis – Financial Results
- BioFish Holding AS (BFISH.OL) Income Statement Analysis – Financial Results
- WNS (Holdings) Limited (WNS) Income Statement Analysis – Financial Results
Teligent, Inc. (TLGT)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: http://www.teligent.com
About Teligent, Inc.
Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.
| Metric | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 45.31M | 65.90M | 67.25M | 66.88M | 44.25M | 33.74M | 18.22M | 8.56M | 7.81M | 6.09M | 3.78M | 4.07M | 4.58M | 2.62M | 2.87M | 3.56M | 3.56M | 4.36M | 15.90M | 19.25M | 34.59M | 33.20M | 34.20M | 35.10M | 31.20M | 28.90M | 28.00M | 24.40M | 22.00M | 20.10M | 18.30M | 16.00M | 15.70M | 18.40M | 17.80M |
| Cost of Revenue | 0.00 | 42.37M | 39.88M | 32.19M | 22.94M | 16.95M | 12.08M | 5.79M | 5.55M | 4.99M | 3.53M | 2.85M | 2.48M | 1.39M | 1.92M | 1.25M | 1.35M | 1.38M | 8.77M | 9.19M | 16.46M | 16.00M | 16.80M | 15.10M | 14.60M | 13.10M | 12.20M | 10.20M | 9.70M | 8.70M | 8.00M | 7.00M | 6.80M | 7.90M | 8.50M |
| Gross Profit | 45.31M | 23.52M | 27.37M | 34.69M | 21.32M | 16.79M | 6.15M | 2.78M | 2.26M | 1.11M | 251.00K | 1.22M | 2.11M | 1.23M | 947.00K | 2.31M | 2.21M | 2.99M | 7.13M | 10.06M | 18.14M | 17.20M | 17.40M | 20.00M | 16.60M | 15.80M | 15.80M | 14.20M | 12.30M | 11.40M | 10.30M | 9.00M | 8.90M | 10.50M | 9.30M |
| Gross Profit Ratio | 100.00% | 35.70% | 40.70% | 51.86% | 48.17% | 49.77% | 33.72% | 32.42% | 28.95% | 18.13% | 6.64% | 29.93% | 45.95% | 47.02% | 33.03% | 64.78% | 62.19% | 68.42% | 44.85% | 52.24% | 52.43% | 51.81% | 50.88% | 56.98% | 53.21% | 54.67% | 56.43% | 58.20% | 55.91% | 56.72% | 56.28% | 56.25% | 56.69% | 57.07% | 52.25% |
| Research & Development | 548.00K | 10.76M | 19.27M | 17.14M | 13.17M | 6.91M | 2.74M | 2.83M | 2.15M | 1.51M | 740.00K | 502.00K | 481.00K | 1.07M | 949.00K | 1.73M | 762.00K | 549.00K | 536.00K | 853.00K | 1.42M | 1.40M | 1.70M | 2.00M | 1.30M | 800.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.33M | 7.99M | 14.06M | 15.70M | 15.00M | 15.00M | 11.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.33M | 7.99M | 14.06M | 15.70M | 15.00M | 15.00M | 11.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 20.79M | 19.90M | 15.01M | 11.34M | 5.98M | 3.48M | 3.08M | 3.08M | 3.23M | 3.60M | 2.78M | 2.43M | 2.11M | 1.68M | 1.80M | 2.42M | 2.36M | 1.42M | 1.37M | 1.15M | 1.00M | 1.00M | 1.00M | 800.00K | 11.50M | 12.50M | 13.80M | 11.70M | 10.40M | 9.60M | 8.10M | 7.50M | 7.90M | 8.40M |
| Operating Expenses | 548.00K | 31.54M | 39.17M | 32.15M | 24.51M | 12.89M | 6.23M | 5.91M | 5.23M | 4.74M | 4.34M | 3.28M | 2.91M | 3.17M | 2.63M | 3.53M | 3.18M | 2.91M | 7.29M | 10.22M | 16.63M | 18.10M | 17.70M | 18.00M | 14.00M | 12.30M | 12.50M | 13.80M | 11.70M | 10.40M | 9.60M | 8.10M | 7.50M | 7.90M | 8.40M |
| Cost & Expenses | 548.00K | 73.92M | 79.05M | 64.34M | 47.44M | 29.83M | 18.31M | 11.70M | 10.78M | 9.73M | 7.87M | 6.13M | 5.39M | 4.56M | 4.55M | 4.78M | 4.53M | 4.29M | 16.06M | 19.41M | 33.09M | 34.10M | 34.50M | 33.10M | 28.60M | 25.40M | 24.70M | 24.00M | 21.40M | 19.10M | 17.60M | 15.10M | 14.30M | 15.80M | 16.90M |
| Interest Income | 0.00 | -21.15M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -962.00K | 17.00K | 3.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25.00K | 7.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 1.61M | 0.00 | 0.00 | 0.00 | 0.00 | 13.00K | 281.00K | 13.00K | 938.00K | 0.00 | 48.00K | 129.00K | 4.00K | 0.00 | 0.00 | 283.00K | 2.13M | 2.75M | 0.00 | 3.40M | 0.00 | 2.00M | 1.30M | 1.00M | 600.00K | 700.00K | 600.00K | 800.00K | 700.00K | 500.00K | 0.00 | 800.00K | 1.00M |
| Depreciation & Amortization | 6.55M | 6.70M | 4.64M | 3.78M | 1.17M | 515.00K | 475.00K | 457.00K | 419.00K | 376.00K | 348.00K | 349.00K | 336.00K | 371.00K | 300.00K | 271.00K | 269.00K | 581.00K | 1.03M | 1.37M | 1.15M | 1.00M | 1.00M | 1.00M | 800.00K | 800.00K | 1.00M | 1.10M | 900.00K | 700.00K | 700.00K | 600.00K | 600.00K | 700.00K | 900.00K |
| EBITDA | 48.60M | -18.34M | -9.02M | -7.92M | 7.88M | 5.94M | 194.00K | -3.64M | -2.53M | -3.25M | -3.74M | -1.70M | -401.00K | -1.63M | -1.27M | -911.00K | -261.00K | 9.97M | 1.15M | -10.22M | -1.04M | 100.00K | -1.10M | 3.00M | 200.00K | 2.70M | -1.60M | 1.80M | 1.60M | 1.70M | 1.40M | 1.40M | 2.10M | 2.90M | 1.10M |
| EBITDA Ratio | 107.27% | -27.83% | -13.42% | -11.84% | 17.80% | 17.60% | 1.06% | -42.52% | -32.45% | -53.35% | -99.05% | -41.75% | -8.75% | -62.02% | -44.40% | -25.60% | -7.34% | 228.55% | 7.22% | -53.10% | -2.99% | 0.30% | -3.22% | 8.55% | 0.64% | 9.34% | -5.71% | 7.38% | 7.27% | 8.46% | 7.65% | 8.75% | 13.38% | 15.76% | 6.18% |
| Operating Income | 44.76M | -8.02M | -11.80M | 2.54M | -3.19M | 3.91M | -82.00K | -3.14M | -2.97M | -3.63M | -4.09M | -2.06M | -806.00K | -1.94M | -1.68M | -1.22M | -972.00K | 79.00K | -161.00K | -157.00K | 1.51M | -900.00K | -300.00K | 2.00M | 2.60M | 3.50M | 3.30M | 400.00K | 600.00K | 1.00M | 700.00K | 900.00K | 1.40M | 2.60M | 900.00K |
| Operating Income Ratio | 98.79% | -12.17% | -17.54% | 3.80% | -7.21% | 11.58% | -0.45% | -36.62% | -38.03% | -59.58% | -108.28% | -50.65% | -17.59% | -73.97% | -58.60% | -34.29% | -27.33% | 1.81% | -1.01% | -0.82% | 4.35% | -2.71% | -0.88% | 5.70% | 8.33% | 12.11% | 11.79% | 1.64% | 2.73% | 4.98% | 3.83% | 5.63% | 8.92% | 14.13% | 5.06% |
| Total Other Income/Expenses | 548.00K | -17.01M | -3.48M | -14.24M | 9.90M | 1.52M | -199.00K | -975.00K | -264.00K | -9.00K | -937.00K | 13.00K | 16.00K | -129.00K | 103.00K | 38.00K | 7.00K | -225.00K | -2.13M | -2.75M | -4.08M | -3.40M | -1.80M | 0.00 | -500.00K | -900.00K | -600.00K | 200.00K | 0.00 | -1.10M | 0.00 | 0.00 | 100.00K | -1.00M | -1.00M |
| Income Before Tax | 45.31M | -25.03M | -15.28M | -11.70M | 6.70M | 5.42M | -281.00K | -4.11M | -3.23M | -3.64M | -5.03M | -2.05M | -790.00K | -2.07M | -1.58M | -1.18M | -965.00K | -146.00K | -2.29M | -2.91M | -2.57M | -4.30M | -2.10M | 0.00 | 2.10M | 2.60M | 2.70M | 600.00K | 0.00 | -100.00K | 0.00 | 0.00 | 1.50M | 1.60M | -100.00K |
| Income Before Tax Ratio | 100.00% | -37.99% | -22.71% | -17.49% | 15.15% | 16.08% | -1.54% | -48.01% | -41.42% | -59.73% | -133.09% | -50.33% | -17.25% | -78.89% | -55.01% | -33.22% | -27.13% | -3.35% | -14.43% | -15.12% | -7.43% | -12.95% | -6.14% | 0.00% | 6.73% | 9.00% | 9.64% | 2.46% | 0.00% | -0.50% | 0.00% | 0.00% | 9.55% | 8.70% | -0.56% |
| Income Tax Expense | 45.31M | 91.00K | -85.00K | 287.00K | 35.00K | 173.00K | -197.00K | -184.00K | -226.00K | -217.00K | -108.00K | -196.00K | -453.00K | -458.00K | -279.00K | -290.00K | -208.00K | 330.00K | -271.00K | 5.86M | -601.00K | -1.30M | -600.00K | -100.00K | 600.00K | 600.00K | 900.00K | -100.00K | 600.00K | -200.00K | 0.00 | 500.00K | 700.00K | 1.00M | 500.00K |
| Net Income | 0.00 | -25.12M | -15.19M | -11.99M | 6.67M | 5.25M | -84.00K | -3.93M | -3.01M | -3.42M | -4.92M | -1.85M | -332.00K | -1.67M | -1.30M | -892.00K | -322.00K | 8.78M | -1.74M | -20.21M | -1.58M | -3.00M | -1.50M | 100.00K | -2.50M | 300.00K | -4.10M | 100.00K | 100.00K | 100.00K | 0.00 | 300.00K | 800.00K | 400.00K | -1.30M |
| Net Income Ratio | 0.00% | -38.13% | -22.59% | -17.92% | 15.07% | 15.56% | -0.46% | -45.86% | -38.52% | -56.17% | -130.23% | -45.51% | -7.25% | -63.63% | -45.27% | -25.07% | -9.05% | 201.19% | -10.94% | -104.99% | -4.58% | -9.04% | -4.39% | 0.28% | -8.01% | 1.04% | -14.64% | 0.41% | 0.45% | 0.50% | 0.00% | 1.88% | 5.10% | 2.17% | -7.30% |
| EPS | 0.00 | -4.67 | -2.85 | -2.26 | 1.26 | 1.05 | -0.02 | -0.99 | -0.76 | -2.30 | -3.31 | -1.24 | -0.23 | -1.30 | -1.08 | -0.77 | -0.28 | 7.68 | -1.59 | -19.81 | -1.65 | -3.17 | -1.59 | 0.10 | -2.57 | 0.30 | -4.90 | 0.10 | 0.10 | 0.20 | 0.00 | 0.30 | 1.00 | 0.60 | -1.80 |
| EPS Diluted | 0.00 | -4.67 | -2.85 | -2.26 | 0.99 | 0.82 | -0.02 | -0.99 | -0.76 | -2.30 | -3.31 | -1.24 | -0.23 | -1.30 | -1.08 | -0.74 | -0.28 | 7.68 | -1.59 | -19.81 | -1.58 | -3.17 | -1.59 | 0.10 | -2.50 | 0.30 | -4.60 | 0.10 | 0.10 | 0.20 | 0.00 | 0.30 | 1.00 | 0.60 | -1.80 |
| Weighted Avg Shares Out | 77.14M | 5.38M | 5.33M | 5.31M | 5.29M | 4.98M | 3.98M | 3.98M | 3.94M | 1.49M | 1.49M | 1.49M | 1.43M | 1.28M | 1.20M | 1.15M | 1.14M | 1.14M | 1.10M | 1.02M | 960.48K | 947.04K | 945.79K | 1.00M | 972.52K | 1.00M | 836.74K | 1.00M | 1.00M | 500.00K | 666.67K | 1.00M | 800.00K | 666.67K | 722.22K |
| Weighted Avg Shares Out (Dil) | 77.14M | 5.38M | 5.33M | 5.31M | 6.71M | 6.42M | 3.98M | 3.98M | 3.94M | 1.49M | 1.49M | 1.49M | 1.43M | 1.28M | 1.20M | 1.20M | 1.15M | 1.14M | 1.10M | 1.02M | 1.00M | 947.04K | 945.79K | 1.00M | 1.00M | 1.00M | 891.30K | 1.00M | 1.00M | 500.00K | 666.67K | 1.00M | 800.00K | 666.67K | 722.22K |
Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Actions Against Teligent, Inc. (TLGT) and June 14 Lead Plaintiff Deadline
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors that it has filed a class action lawsuit against Teligent, Inc. (“Teligent” or the “Company”) (NASDAQ: TLGT) and one of its executives...
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teligent, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teligent, Inc. (“Teligent” or “the Company”) (NASDAQ: TLGT) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teligent, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teligent, Inc. (“Teligent” or “the Company”) (NASDAQ: TLGT) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Teligent, Inc.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 14, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Teligent, Inc. (“Teligent” or the “Company”) (NASDAQ: TLGT) investors...
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Teligent, Inc.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming June 14, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Teligent, Inc. (“Teligent” or the “Company”)...
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Teligent, Inc. Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that acquired Teligent, Inc.(“Teligent” or the “Company”) (NASDAQ: TLGT) securities between May 2,...
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Teligent, Inc. To Contact The Firm
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Teligent, Inc. ("Teligent" or the "Company")(NASDAQ:TLGT) of the June 14, 2019 deadline to seek the role of lead plaintiff in a federal securities class action...
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Teligent, Inc. Investors (TLGT)
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Teligent, Inc. (“Teligent” or the “Company”) (NASDAQ: TLGT) securities between May 2, 2017 and November 7, 2017,...
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Teligent, Inc. Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Teligent, Inc. (“Teligent” or the “Company”) (NASDAQ: TLGT) investors concerning the Company and its officers’ possible violations of federal securities laws. If you are a shareholder...
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Teligent, Inc. Investors (TLGT)
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Teligent, Inc. (“Teligent” or the “Company”) (NASDAQ: TLGT) investors concerning the Company and its officers’ possible violations of federal securities laws. On November 6, 2017, the...
Source: https://incomestatements.info
Category: Stock Reports